AMP deaminase 2: Difference between revisions
Jump to navigation
Jump to search
m (Bot: HTTP→HTTPS) |
imported>Boghog (consistent citation formatting) |
||
| Line 1: | Line 1: | ||
{{Infobox_gene}} | {{Infobox_gene}} | ||
'''AMP deaminase 2''' is an [[enzyme]] that in [[humans]] is encoded by the ''AMPD2'' [[gene]].<ref name="pmid1400401">{{cite journal | vauthors = Mahnke-Zizelman DK, Sabina RL | title = Cloning of human AMP deaminase isoform E cDNAs. Evidence for a third AMPD gene exhibiting alternatively spliced 5'-exons | journal = J Biol Chem | volume = 267 | issue = 29 | pages = 20866–77 |date=Nov 1992 | pmid = 1400401 | pmc = | doi = }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: AMPD2 adenosine monophosphate deaminase 2 (isoform L)| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=271| accessdate = }}</ref> | '''AMP deaminase 2''' is an [[enzyme]] that in [[humans]] is encoded by the ''AMPD2'' [[gene]].<ref name="pmid1400401">{{cite journal | vauthors = Mahnke-Zizelman DK, Sabina RL | title = Cloning of human AMP deaminase isoform E cDNAs. Evidence for a third AMPD gene exhibiting alternatively spliced 5'-exons | journal = J Biol Chem | volume = 267 | issue = 29 | pages = 20866–77 |date=Nov 1992 | pmid = 1400401 | pmc = | doi = }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: AMPD2 adenosine monophosphate deaminase 2 (isoform L)| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=271| accessdate = }}</ref> | ||
High AMPD2 expression levels correlate with poor patient outcome and a proliferative tumor phenotype in undifferentiated pleomorphic sarcoma (UPS). <ref>{{cite journal | vauthors = Orth MF, Gerke JS, Knösel T, Altendorf-Hofmann A, Musa J, Alba-Rubio R, Stein S, Hölting TL, Cidrea-Aranaz F, Romero-Pérez L, Dallmayer M, Baldauf MC, Marchetto A, Sannino G, Knott MM, Wehweck F, Ohmura S, Li J, Hakozaki M, Kirchner T, Dandekar T, Butt E, Grünewald TG | display-authors = 6 | title = Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma | journal = International Journal of Cancer | date = September 2018 | pmid = 30267407 | doi = 10.1002/ijc.31903 }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 18:45, 8 October 2018
| VALUE_ERROR (nil) | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Aliases | |||||||
| External IDs | GeneCards: [1] | ||||||
| Orthologs | |||||||
| Species | Human | Mouse | |||||
| Entrez |
|
| |||||
| Ensembl |
|
| |||||
| UniProt |
|
| |||||
| RefSeq (mRNA) |
|
| |||||
| RefSeq (protein) |
|
| |||||
| Location (UCSC) | n/a | n/a | |||||
| PubMed search | n/a | n/a | |||||
| Wikidata | |||||||
| |||||||
AMP deaminase 2 is an enzyme that in humans is encoded by the AMPD2 gene.[1][2]
High AMPD2 expression levels correlate with poor patient outcome and a proliferative tumor phenotype in undifferentiated pleomorphic sarcoma (UPS). [3]
References
- ↑ Mahnke-Zizelman DK, Sabina RL (Nov 1992). "Cloning of human AMP deaminase isoform E cDNAs. Evidence for a third AMPD gene exhibiting alternatively spliced 5'-exons". J Biol Chem. 267 (29): 20866–77. PMID 1400401.
- ↑ "Entrez Gene: AMPD2 adenosine monophosphate deaminase 2 (isoform L)".
- ↑ Orth MF, Gerke JS, Knösel T, Altendorf-Hofmann A, Musa J, Alba-Rubio R, et al. (September 2018). "Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma". International Journal of Cancer. doi:10.1002/ijc.31903. PMID 30267407.
External links
- Human AMPD2 genome location and AMPD2 gene details page in the UCSC Genome Browser.
Further reading
- Bausch-Jurken MT, Mahnke-Zizelman DK, Morisaki T, Sabina RL (1992). "Molecular cloning of AMP deaminase isoform L. Sequence and bacterial expression of human AMPD2 cDNA". J. Biol. Chem. 267 (31): 22407–13. PMID 1429593.
- Van den Bergh F, Sabina RL (1996). "Characterization of human AMP deaminase 2 (AMPD2) gene expression reveals alternative transcripts encoding variable N-terminal extensions of isoform L". Biochem. J. 312 (Pt 2): 401–10. doi:10.1042/bj3120401. PMC 1136276. PMID 8526848.
- Mahnke-Zizelman DK, van den Bergh F, Bausch-Jurken MT, et al. (1996). "Cloning, sequence and characterization of the human AMPD2 gene: evidence for transcriptional regulation by two closely spaced promoters". Biochim. Biophys. Acta. 1308 (2): 122–32. doi:10.1016/0167-4781(96)00089-9. PMID 8764830.
- Haas AL, Sabina RL (2003). "N-terminal extensions of the human AMPD2 polypeptide influence ATP regulation of isoform L". Biochem. Biophys. Res. Commun. 305 (2): 421–7. doi:10.1016/S0006-291X(03)00787-3. PMID 12745092.
- Beausoleil SA, Villén J, Gerber SA, et al. (2006). "A probability-based approach for high-throughput protein phosphorylation analysis and site localization". Nat. Biotechnol. 24 (10): 1285–92. doi:10.1038/nbt1240. PMID 16964243.
- Olsen JV, Blagoev B, Gnad F, et al. (2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks". Cell. 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.
 | This article on a gene on human chromosome 1 is a stub. You can help Wikipedia by expanding it. |